Literature DB >> 1281633

Molecular mapping of human band 3 aging antigenic sites and active amino acids using synthetic peptides.

M M Kay1.   

Abstract

An aging antigen, senescent cell antigen appears on old cells and marks them for death by initiating the binding of IgG autoantibody and subsequent removal by phagocytes. This antigen is derived from the major anion transport protein, protein band 3, that is involved in respiration and acid base balance. We use synthetic peptides from the transmembrane, anion transport segment of band 3 to "walk" band 3 to identify potential aging antigenic sites. A competitive inhibition assay with affinity purified IgG autoantibody from senescent red cells was used. Results indicate that: aging antigenic sites reside on human band 3 residues 538-554, 593-601, and 812-830; and that the smallest residues which act as aging antigenic sites are 593-601 and 813-818. The contribution of lysine and/or arginine to antigenicity is examined by synthesizing peptide analogs in which glycines or arginines are substituted for lysines or arginines. Substitution of neutral glycine for the positively charged amino acids arginine or lysine or both arginine and lysine did not result in a significant difference in antigenicity between the analog and the native band 3 peptide. Substitution of the positively charged arginine for the positively charged lysine resulted in a significant reduction in antigenicity. The chicken sequence of band 3 peptides 538-554 and 812-827 differs from that of the human peptides at several sites. Antigenicity of these chicken "analogs" were tested and compared to the human peptides. The data suggest that the three-dimensional configuration of band 3 segments plays a dominant role in defining the antigenic determinants reactive with senescent cell IgG autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281633     DOI: 10.1007/BF01024959

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  55 in total

1.  Functional topography of band 3: specific structural alteration linked to functional aberrations in human erythrocytes.

Authors:  M M Kay; G J Bosman; C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: localization of the active antigenic sites.

Authors:  M M Kay; J J Marchalonis; J Hughes; K Watanabe; S F Schluter
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Evidence for a malarial parasite interaction site on the major transmembrane protein of the human erythrocyte.

Authors:  M J Friedman; M Fukuda; R A Laine
Journal:  Science       Date:  1985-04-05       Impact factor: 47.728

Review 4.  Antigenicity, storage, and aging: physiologic autoantibodies to cell membrane and serum proteins and the senescent cell antigen.

Authors:  M M Kay; K Sorensen; P Wong; P Bolton
Journal:  Mol Cell Biochem       Date:  1982-11-26       Impact factor: 3.396

5.  Immune elimination of aging platelets by autologous monocytes: role of membrane-specific autoantibody.

Authors:  N Khansari; H H Fudenberg
Journal:  Eur J Immunol       Date:  1983-12       Impact factor: 5.532

6.  Mechanisms for the removal of senescent human erythrocytes from circulation: specificity of the membrane-bound immunoglobulin G.

Authors:  N Khansari; G F Springer; E Merler; H H Fudenberg
Journal:  Mech Ageing Dev       Date:  1983-01       Impact factor: 5.432

7.  Erythrocyte homeostasis: antibody-mediated recognition of the senescent state by macrophages.

Authors:  J A Singer; L K Jennings; C W Jackson; M E Dockter; M Morrison; W S Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Immunolocalization of band 3 protein in normal and cystic fibrosis skin.

Authors:  D J Hazen-Martin; G Pasternack; S S Spicer; D A Sens
Journal:  J Histochem Cytochem       Date:  1986-06       Impact factor: 2.479

9.  Molecular mapping of human band 3 anion transport regions using synthetic peptides.

Authors:  M M Kay
Journal:  FASEB J       Date:  1991-01       Impact factor: 5.191

10.  Immunocytochemistry of band 3 protein in kidney and other tissues of control and cystic fibrosis patients.

Authors:  D J Hazen-Martin; G Pasternack; R A Hennigar; S S Spicer; D A Sens
Journal:  Pediatr Res       Date:  1987-03       Impact factor: 3.756

View more
  4 in total

1.  Vitamin E prevents oxidative modification of brain and lymphocyte band 3 proteins during aging.

Authors:  J E Poulin; C Cover; M R Gustafson; M B Kay
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

2.  Monoclonal antibodies that react with human band 3 residues 542-555 recognize different conformations of this protein in uninfected and Plasmodium falciparum infected erythrocytes.

Authors:  N Guthrie; I E Crandall; S Marini; G F Fasciglione; I W Sherman
Journal:  Mol Cell Biochem       Date:  1995-03-23       Impact factor: 3.396

Review 3.  Mechanisms tagging senescent red blood cells for clearance in healthy humans.

Authors:  Hans U Lutz; Anna Bogdanova
Journal:  Front Physiol       Date:  2013-12-25       Impact factor: 4.566

4.  Molecular Simulations of Intact Anion Exchanger 1 Reveal Specific Domain and Lipid Interactions.

Authors:  Dario De Vecchis; Reinhart A F Reithmeier; Antreas C Kalli
Journal:  Biophys J       Date:  2019-08-30       Impact factor: 4.033

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.